Josh Cline's Linkedin Analytics

Nobody ever told Josh Cline: “Think Different.” He just does. Being the Confounding “Dyslexic Thinker” at Generative Buzz, Josh has never given up on the idea that all marketing strategies must map to your business goals and objectives. AI is a readily available tool. The hard part is figuring out where––and how––to use it. At Generative Buzz, we help companies overcome this challenge, and deploy AI effectively with: AI use-cases definition AI model identification AI implementation AI prompt engineering When you start to Think Different about AI, you’ll start to improve your lead generation, and close more deals. Adding “Thinker” to Dyslexic… Josh Cline is a Dyslexic Thinker. (Like Steve Jobs, Richard Branson, and Einstein.) He has helped earn his companies over $100M in 20 years. As a business and marketing executive, he applies his dyslexic mind to the most significant areas of opportunity... How does Dyslexic Thinking work for Josh and the organizations that hire him? Since most dyslexics think in images instead of words, dyslexia activates parts of the brain that adults (especially in business) fail to use. He sees opportunities where others see only problems. In a Johnson O’Connor aptitude test, Josh scored 99 percent in “Ideaphoria,” which is how we measure the flow of ideas. He scored 95 percent in “Foresight.” Josh’s skill lies in crafting a vision, which he often arrives at in mere seconds to minutes, and creates customer-focused, high-performance cultures and solutions. Josh helped launch and grow a startup to $40M ARR. As the strategic executive planner, Josh’s team delivered global business and marketing strategies for over 250 companies. He was instrumental in the rapid expansion and acquisition of the start-up iOnRoad Technologies, acquired by Harman International Industries, Tel Aviv. Josh advised the CEO of MediSafe, developing a business model, branding, and marketing for the medical management platform. He helped obtain the first $1M in financing. MediSafe is now serving 7M registered users--including top-tier pharma clients--using Josh’s original strategic vision. He restructured Randolph Eye Associates, creating systems that improved performance and efficiency. His relationships were directly responsible for its negotiated acquisition at 2.5X valuation. A development natural, Josh has raised over $4M for community organizations. He has an ability to spot and capitalize on market trends. In his free time, Josh loves family time, sports, helping others and giving back.